Screener
Guardian Pharmacy Services GRDN Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Guardian Pharmacy Services in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338074
| (In thousands, except per share amounts) | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2026 |
|---|---|---|---|---|
| Cost of goods sold | 276,188 | 271,724 | 541,147 | 532,010 |
| Gross profit | 68,146 | 80,044 | 132,495 | 156,353 |
| Selling, general, and administrative expenses | 55,566 | 59,400 | 106,910 | 118,034 |
| Operating income | 12,580 | 20,644 | 25,585 | 38,319 |
| Other expenses (income): | ||||
| Interest expense | 172 | 154 | 342 | 308 |
| Other expense (income), net | (179) | (9,302) | (450) | (10,074) |
| Total other expenses (income) | (7) | (9,148) | (108) | (9,766) |
ITEM 1. Financial Statements
FAQ
- What is Guardian Pharmacy Services's operating income?
- Guardian Pharmacy Services (GRDN) reported operating income of $20.64M in Q2 2026.
- How has Guardian Pharmacy Services's operating income changed year-over-year?
- Guardian Pharmacy Services's operating income increased by 64.1% year-over-year, from $12.58M to $20.64M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Guardian Pharmacy Services's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude